Nivolumab combined docetaxel versus nivolumab in patients with previously treated nonsmall cell lung cancer: a phase 2 study.
Wang Y, Hao Q, Nie J, Dai L, Hu W, Zhang J, Chen X, Ma X, Tian G, Han J, Han S, Wu D, Long J, Zhang Z, Fang J.
Wang Y, et al. Among authors: zhang j, zhang z.
Anticancer Drugs. 2024 Jun 1;35(5):412-417. doi: 10.1097/CAD.0000000000001569. Epub 2024 Jan 22.
Anticancer Drugs. 2024.
PMID: 38240789
Clinical Trial.